Paroxysmal Supraventricular Tachycardia

• FDA label_change · 2024-08-13
  FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc. to update labeling for this long-a…

• FDA label_change · 2016-11-18
  FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)

  FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.

• FDA label_change · 2010-02-04
  FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for Adenosine from Mylan Institutional LLC, resulting in changes to the product labeling.

• FDA label_change · 2008-01-14
  FDA Approved: ADENOSINE — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for Adenosine from Sagent Pharmaceuticals, updating the labeling for the product.